It’s official: Meet 4 of the country’s most impressive healthcare startups
A quartet of companies on Wednesday were selected among the 44 companies that presented at MedCity INVEST, MedCity News' healthcare investing conference.
A quartet of companies on Wednesday were selected among the 44 companies that presented at MedCity INVEST, MedCity News' healthcare investing conference.
"Traditionally we waited for folks to come to us."
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Also, read about Sequenom's very important patent fight, a petition for a unique patient ID, and a gentle critique on the Cancer Moonshot.
Also, the latest hospital cyber attack (a ransomware attack), Zika gets political, a poll on the best kind of HIMSS keynotes, and the Valeant obituaries are rolling in.
Also, Oscar grabs a Google VP as its CTO, new telemedicine reimbursements and a new policy concept: a $3 billion federal prize for AIDS breakthroughs.
Also, a preview of Valeant's "watershed" moment, do-it-yourself CRISPR and health insurance experiments that are gaining traction.
Also, previews of the CRISPR patent fight and Toshiba medical auction happening this week.
Also, HIMSS keynote strategy mocked, ACOs continues to be pummeled, and a new European initiative to speed up approval of innovative drugs.
A simple question (followed by a shameless plug): What will we see from HIMSS culminate in real action the rest of the year? An embrace of secure patient portals? Interoperability policies turned into action? Meaningful progress on providers ready for pay-for-value? Better EMRs? So many discussions at HIMSS. To get a better gauge on what […]
Also, more details on the Trump healthcare plan and a ridiculous wellness incentive.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Neil Versel and guests break down the week of HIMSS16.
Also, getting real on HIMSS16 turnout, a hard look at medical scribes and Mitt Romney makes an appearance.
Also, Google gets into the fight for Zika, a new cancer startup using "PARP" inhibitors, and New York claims some insurance companies are rationing care around Hep C drugs.
Either way, it's put up or shut up time with everything that comes after HIMSS.
Also, HIMSS shows the JP Morgan crowd how its done, HISTalkapalooza highlights and more updates from the show floor.